Ikena Oncology, Inc.IKNANASDAQ

Revenue (LTM)

Net Income (LTM)

$-52M

-6.4% YoY

Free Cash Flow

$-48M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	31	16↓49.6%	9↓41.3%	0	0
Gross Profit	-16	14↑184.3%	8↓40.1%	-0↓106.0%	0
Operating Income	-34	-71↓107.7%	-75↓6.4%	-55↑27.7%	-48↑11.2%
Net Income	-34	-69↓101.6%	-68↑0.9%	-49↑27.8%	-52↓6.4%
EBITDA	-34	-70↓108.8%	-74↓6.0%	-49↑34.7%	-48↑0.3%
EPS Diluted	-0.95	-1.90↓100.0%	-1.63↑14.2%	-1.02↑37.4%	0.00

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	232	60↓74.2%	120↑100.1%	39↓67.1%	35↓11.2%
Total Current Assets	237	160↓32.3%	179↑11.7%	127↓28.8%	76↓40.4%
Total Assets	248	172↓30.5%	192↑11.5%	142↓26.3%	83↓41.5%
Total Current Liabilities	27	22↓20.9%	14↓33.9%	11↓24.1%	0
Total Liabilities	40	25↓36.8%	22↓11.7%	16↓30.3%	7↓54.9%
Total Equity	208	147↓29.3%	170↑15.5%	126↓25.8%	76↓39.8%
Total Debt	7	6↓18.5%	11↑88.6%	8↓30.0%	0
Net Debt	-225	-54↑75.9%	-109↓101.3%	-32↑70.8%	-35↓9.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-60	-74↓23.0%	-80↓7.6%	-46↑42.3%	-48↓4.0%
Capital Expenditure	-2	-1↑18.7%	-0↑71.1%	0	0
Free Cash Flow	-62	-76↓21.8%	-80↓6.1%	-46↑42.6%	-48↓4.0%
Stock-Based Comp	5	8↑45.4%	8↑1.4%	5↓30.6%	15↑190.7%
Net Change in Cash	70	-172↓347.1%	60↑135.0%	-81↓234.0%	82↑201.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance